Biomarkers in cancer detection and monitoring of therapeutics. Volume 2, Diagnostic and therapeutic applications /

Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focu...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Sobti, Ranbir Chander (Editor), Watanabe, Masatoshi (Editor), Sobti, Aastha (Editor)
Format: eBook
Language:English
Published: London, United Kingdom ; San Diego, CA : Academic Press, [2024]
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume 2: Diagnostic and Therapeutic Applications
  • Copyright
  • Contents
  • Contributors
  • Preface
  • Chapter One: Oral squamous cell carcinoma
  • 1. Oral cancer
  • 2. Oral squamous cell carcinoma
  • 3. Epidemiology
  • 4. Etiology
  • Impact of tobacco products
  • Patterns and trends in tobacco use
  • Use of smokeless tobacco products
  • 5. Precursor lesions
  • 5.1. Genetically acquired potentially malignant disorders
  • 5.2. Tobacco-induced potentially malignant disorders
  • 5.3. Immune-mediated potentially malignant disorders
  • 5.4. Genetically inherited potentially malignant disorders
  • 6. Oral epithelial dysplasia
  • 7. Pathogenesis
  • 7.1. Autophagy
  • 8. Cancer stem cells
  • 9. Tumor microenvironment
  • 10. Epithelial-mesenchymal transition
  • 11. Metastasis
  • 12. Oral bacteria in oral carcinogenesis
  • 13. Clinical features
  • Salient features specific to subsite
  • 14. Diagnosis
  • 14.1. Adjunctive aids for early detection
  • Nano-diagnostics
  • Lab-on-chip/microfluidics
  • Liquid biopsy
  • Microarray technology
  • Next generation sequencing
  • Omics
  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Staging of oral squamous cell carcinoma
  • 15. Histopathological features
  • 16. Treatment
  • 16.1. Surgical resection
  • Management of primary lesion
  • Management of neck nodes
  • 16.2. Chemotherapy
  • Adjuvant chemotherapy
  • Adjuvant chemoradiotherapy
  • Primary chemoradiation
  • Induction chemotherapy
  • In the management of metastatic disease
  • 16.3. Nanotechnology in carcinoma therapy
  • Chemoprevention using nanoparticles
  • 16.4. Radiotherapy
  • 16.5. Immunotherapy
  • Cytokines
  • Toll-like receptors
  • Immune checkpoint inhibitors
  • Immune checkpoint activators
  • 16.6. Therapeutic markers
  • 17. Prognosis
  • 17.1. Clinical factors
  • 17.2. Histopathological factors
  • 17.3. Metastasis
  • References
  • Chapter Two: Genetic predisposition and pathophysiology of oral squamous cell carcinoma
  • 1. Introduction
  • 1.1. Microbial flora
  • 1.2. Oral microbial flora
  • 1.3. Oral microbial flora and cancer
  • 1.4. Squamous cell carcinoma of the head and neck
  • 2. Oral squamous cell carcinoma and glucose transporters
  • 2.1. Human glucose transporters
  • 2.2. Glucose transporters (GLUT 1) and its expression
  • 3. Oral squamous cell carcinoma and methylated genes
  • 3.1. Variation of methylated genes in cancer conditions
  • 3.2. DNA methylation modifications and its implications
  • References
  • Chapter Three: Molecular biomarkers in gastric cancer
  • 1. Introduction
  • 2. RNF43
  • 3. APC
  • 4. ARID1A
  • 5. ARID2
  • 6. MSI
  • 7. MALTA1-GLT1 fusion
  • 8. TP53
  • 9. RB1
  • 10. ERBB2
  • 11. C-MET
  • 12. EGFR
  • 13. PD-L1
  • 14. Epstein-Barr virus
  • 15. VEGF-A
  • 16. CD44
  • 17. E-cadherin
  • 18. Matrix metalloproteinases (MMPs)
  • 19. Conclusions